Desentum
Desentum is an antibodies for long term allergy protection founded in 2011.
1
Funding Rounds
$9.1m
Money raised
Funding series
Funding Series Analysis
The company Desentum has raised a total of $9.1m in funding over 1 rounds.
Key Insights:
- Desentum January 2022 Funding Round: $9.1m
Desentum January 2022 Funding Round
$9.1m
Industries
Desentum is active in the following industries: